The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Credit: Getty Images. Findings showed the device may increase the risk of fetal or neonatal/infant death. Among women with a short cervix, the use of a cervical pessary did not result in a reduction ...

Cervical pessaries didn't reduce risk of preterm birth and fetal death prior to 37 weeks gestation in high-risk singleton pregnancies, according to the randomized TOPS trial. The intravaginal device ...

Please provide your email address to receive an email when new articles are posted on . Preterm delivery or neonatal death occurred in 45.5% of the pessary group vs. 45.6% of the usual care group.

Most women stuck with pessary treatment for symptomatic pelvic organ prolapse (POP), according to a long-term study. In a prospective study of 312 Chinese women with symptomatic POP, 75% continued ...

Please provide your email address to receive an email when new articles are posted on . Patient-reported improvement of pelvic organ prolapse symptoms was similar for pessary vs. surgery, but ...

A study comparing cervical pessary and vaginal progesterone for the prevention of preterm birth in women with a short cervix of ≤ 35 mm found no significant difference between the interventions for ...

Women with a short cervix around 20 weeks of pregnancy have an increased risk of preterm birth. Preventing preterm birth in pregnant women with a short cervix is a crucial step in protecting the ...

The standard nonsurgical treatment for pelvic organ prolapse does not appear to work as well as surgery to correct the problem, Dutch researchers have found. Pelvic organ prolapse is an uncomfortable ...

TORONTO--(BUSINESS WIRE)--Cosm Medical proudly announces FDA clearance for Gynethotics™ Pessaries, marking it as the first personalized pessary available to patients. This milestone follows a recent ...